Cargando…
Critical Adjuvant Influences on Preventive Anti-Metastasis Vaccine Using a Structural Epitope Derived from Membrane Type Protease PRSS14
We tested how adjuvants effect in a cancer vaccine model using an epitope derived from an autoactivation loop of membrane-type protease serine protease 14 (PRSS14; loop metavaccine) in mouse mammary tumor virus (MMTV)-polyoma middle tumor-antigen (PyMT) system and in 2 other orthotopic mouse systems...
Autores principales: | Kim, Ki Yeon, Cho, Eun Hye, Yoon, Minsang, Kim, Moon Gyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458796/ https://www.ncbi.nlm.nih.gov/pubmed/32895620 http://dx.doi.org/10.4110/in.2020.20.e33 |
Ejemplares similares
-
Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies
por: Kim, Ki Yeon, et al.
Publicado: (2019) -
Intramembrane proteolysis of an extracellular serine protease, epithin/PRSS14, enables its intracellular nuclear function
por: Cho, Youngkyung, et al.
Publicado: (2020) -
A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase CβII
por: Yoon, Joobyoung, et al.
Publicado: (2020) -
Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer
por: Kim, Sauryang, et al.
Publicado: (2016) -
Environment-Sensitive Ectodomain Shedding of Epithin/PRSS14 Increases Metastatic Potential of Breast Cancer Cells by Producing CCL2
por: Jang, Jiyoung, et al.
Publicado: (2022)